The NEUROMARK™ System is designed to treat symptoms of chronic rhinitis safely and effectively in the ENT physician’s office with a high degree of patient comfort. The system is engineered to gently apply controlled low-power Radio Frequency (RF) energy to target regions of the nasal cavity to disrupt the parasympathetic nerve signals and halt the inflammatory response, thereby eliminating core symptoms such as congestion and rhinorrhea. Using proprietary algorithms and biofeedback monitoring features, the intelligent system precisely delivers energy to the target nerve-dense region while restricting energy and minimizing damage to surrounding tissue and improving patient comfort.
Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO Brian Shields and CTO David Townley, culminating from their work at the BioInnovate Ireland program at the National University, Galway.
Co-founder & CEO
Co-founder & CTO
Chairman of the Board
Former President, Medtronic Surgical Technologies
Partner & CFO,
Fountain Healthcare Partners
Stay up to date with the latest news from Neurent Medical